Maine legislation · 132nd Legislature
Maine LD1687: An Act to Clarify and Increase Access to HIV Prevention Medications
Status: Signed into law, July 1, 2025
What the bill says
An Act to Clarify and Increase Access to HIV Prevention Medications.
From the engrossed text:
An Act to Clarify and Increase Access to HIV Prevention Medications Sec. 1. 22 MRSA §3197 is enacted to read: §3197. Prescribing, dispensing and administering HIV prevention drugs 1. Definition. As used in this section, unless the context otherwise indicates, "HIV prevention drug" has the same meaning as in Title 32, section 13786-E, subsection 1, paragraph B. 2. Reimbursement for pharmacists prescribing, dispensing and administering HIV prevention drugs. No later than January 1, 2027, the department shall provide reimbursement under the MaineCare program to a pharmacist for prescribing, dispensing and administering HIV prevention drugs under Title 32, section 13786-E. The department: A. Shall provide coverage for services provided by the pharmacist under this subsection; B. Shall authorize a pharmacist to bill the carrier and receive direct payment for a service under this subsection that the pharmacist provides to a MaineCare member and shall identify the pharmacist as the provider in the billing and the claims process for payment of the service; and C. May not impose on a pharmacist a practice, education or collaboration requirement that is inconsistent with or more restrictive than a requirement of state law or an agency or board rule for the pharmacist to receive payment for a service provided under this subsection. 3. Reimbursement model. No later than January 1, 2027, the department shall create …
Sponsors
- Matthew Moonen (D, 117) · primary sponsor
- Michelle Boyer (D, 123)
- Sally Cluchey (D, 52)
- Ryan Fecteau (D, 132)
- Anne-Marie Mastraccio (D, 142)
- Kristi Mathieson (D, 151)
Latest actions
- : On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table PASSED TO BE ENACTED in concurrence.
- : On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence
- : PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.
- : Report READ and ACCEPTED, in concurrence.READ ONCE.Committee Amendment "A" (H-642) READ and ADOPTED, in concurrence.Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (H-642), in concurrence.Ordered sent down forthwith.
- : CONSENT CALENDAR - FIRST DAYUnder suspension of the rules CONSENT CALENDAR - SECOND DAY.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-642).Sent for concurrence. ORDERED SENT FORTHWITH.
- : The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES in concurrence
- : Committee on Health Coverage, Insurance and Financial Services suggested and ordered printed. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES.Sent for concurrence. ORDERED SENT FORTHWITH.
Subjects: HIV PREVENTION MEDS, Legislature, Senate, HEALTH CARE PERSONNEL, Other, PHARMACISTS
Common questions
- What is LD1687?
- LD1687 is a bill in the Maine Legislature (132nd Legislature): An Act to Clarify and Increase Access to HIV Prevention Medications.
- What does LD1687 do?
- In its own words: An Act to Clarify and Increase Access to HIV Prevention Medications.
- What is the status of LD1687?
- Signed into law as of July 1, 2025. Latest action: On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table PASSED TO BE ENACTED in concurrence. (June 25, 2025).
- Who sponsored LD1687?
- Matthew Moonen (D, 117), with 5 co-sponsors.
- Where is the official record for LD1687?
- On the Maine Legislature website: https://legislature.maine.gov/legis/bills/display_ps.asp?LD=1687&snum=132
Source: official Maine record. Tracked by Delilah, AI for legislation across all 50 states and Congress.